-+ 0.00%
-+ 0.00%
-+ 0.00%

LYELL IMMUNOPHARMA - PROSPECTUS COVERS RESALE OF UP TO 7,428,040 SHARES OF COMMON STOCK - SEC FILING

Reuters·11/13/2026 21:05:47

Please log in to view news